[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"case:isa-therapeutics-bv-30284229:header:guest:personal:":3,"case:isa-therapeutics-bv-30284229:documents:guest:personal::{}":77,"case:isa-therapeutics-bv-30284229:document-search:":190},{"id":4,"slug":5,"name":6,"trade_names":7,"status":8,"procedure":9,"procedure_type":10,"insolvency_number":29,"case_number":29,"declared_on":30,"terminated_on":14,"termination_reason":14,"kvk_number":31,"legal_form":32,"sbi":14,"court":35,"judge":38,"judge_source":39,"curator":40,"location":46,"counts":55,"pages":59,"follower_count":58,"report_count":56,"last_report_on":71,"last_update_at":72,"freshness":73,"linked":76},"01M4M3D0K60HJ7BCA8HP67MCJ1","isa-therapeutics-bv-30284229","ISA Therapeutics B.V.",[],"active","bankruptcy",{"id":11,"key":9,"family":12,"name":13,"short_name":14,"legal_basis":15,"features":19},"01M3Y8CPCPT53NPXHK39BWK1QY","insolvency","Faillissement",null,{"name":16,"provision":17,"url":18},"Faillissementswet","Titel I (art. 1 e.v.)","https:\u002F\u002Fwetten.overheid.nl\u002FBWBR0001860",[20,21,22,23,24,25,26,27,28],"reports","financials","creditors","assets","investigations","curator_workspace","appointments","court_decisions","portfolio_monitoring","F.13\u002F24\u002F307","2024-07-18","30284229",{"value":33,"source":34},"BV","cir",{"name":36,"slug":37,"location":14},"Rechtbank Amsterdam","amsterdam","mr. W.M. de Vries",{"type":34,"report_number":14,"published_on":14},{"name":41,"slug":42,"law_firm":43,"city":44,"verified":45},"mr. B.F. van Noort","bf-van-noort","Van Diepen Van der Kroef Advocaten","Amsterdam",false,{"street":47,"house_number":48,"addition":14,"postal_code":49,"city":50,"municipality":50,"province":51,"lat":52,"lng":53,"kind":54,"source":34},"De Limes","7","2342DH","Oegstgeest","Zuid-Holland",52.170861,4.449804,"business",{"reports":56,"documents":57,"assets":56,"investigations":58,"news":58},9,20,0,{"overview":60,"reports":62,"financials":63,"investigations":64,"assets":65,"timeline":66,"documents":67,"news":68,"company":69,"compare":70},{"index":61,"ads":45},true,{"index":61,"ads":45},{"index":61,"ads":45},{"index":45,"ads":45},{"index":61,"ads":45},{"index":61,"ads":45},{"index":61,"ads":45},{"index":45,"ads":45},{"index":61,"ads":45},{"index":45,"ads":45},"2026-08-19","2026-10-10T23:47:33+00:00",{"last_checked_at":74,"last_reconciled_at":74,"stale":45,"status":75},"2026-10-10T23:47:03+00:00","current",{"continued_from":14,"continued_as":14},{"data":78},[79,86,91,100,106,110,116,120,127,131,137,141,148,152,158,163,170,174,179,183],{"kind":80,"id":81,"title":82,"report_number":56,"report_date":71,"date":71,"pages":56,"category":83,"source":84,"url":85,"searchable":61},"report","01M4M3DVV8RR9R7E6Q8FWEAE2R","Financieel verslag  19-08-2026","official","rechtspraak","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DVV8RR9R7E6Q8FWEAE2R.pdf",{"kind":80,"id":87,"title":88,"report_number":56,"report_date":71,"date":71,"pages":89,"category":83,"source":84,"url":90,"searchable":61},"01M4M3DXQ77DKFYQCSY6Q7M2A7","Verslag:  19-08-2026",24,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DXQ77DKFYQCSY6Q7M2A7.pdf",{"kind":92,"id":93,"title":94,"report_number":14,"date":95,"pages":96,"category":83,"source":34,"url":14,"searchable":45,"publication_type":97,"publication_number":98,"stored_at":74,"download_url":99},"publication","01M4M3D0PA0EQGVMH0RCE0B2RK","Vervanging rechter-commissaris mr. C.H. Rombouts door mr. W.M. de Vries.","2026-07-03",1,"other","13.ams.24.307.F.1328.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Fisa-therapeutics-bv-30284229\u002Fpublications\u002F01M4M3D0PA0EQGVMH0RCE0B2RK\u002Fdownload",{"kind":80,"id":101,"title":102,"report_number":103,"report_date":104,"date":104,"pages":56,"category":83,"source":84,"url":105,"searchable":61},"01M4M3DRRPM9JG46ZNMZV6VER2","Financieel verslag  19-05-2026",8,"2026-05-19","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DRRPM9JG46ZNMZV6VER2.pdf",{"kind":80,"id":107,"title":108,"report_number":103,"report_date":104,"date":104,"pages":89,"category":83,"source":84,"url":109,"searchable":61},"01M4M3DTHBPRW2ZC46AG9BD2EX","Verslag:  19-05-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DTHBPRW2ZC46AG9BD2EX.pdf",{"kind":80,"id":111,"title":112,"report_number":113,"report_date":114,"date":114,"pages":89,"category":83,"source":84,"url":115,"searchable":61},"01M4M3DNXNXE7QDEC35TK5WK9Y","Verslag: 19-02-2026",7,"2026-02-19","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DNXNXE7QDEC35TK5WK9Y.pdf",{"kind":80,"id":117,"title":118,"report_number":113,"report_date":114,"date":114,"pages":56,"category":83,"source":84,"url":119,"searchable":61},"01M4M3DQ7CT23VBCTY0MMJT9GV","Financieel verslag 19-02-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DQ7CT23VBCTY0MMJT9GV.pdf",{"kind":80,"id":121,"title":122,"report_number":123,"report_date":124,"date":124,"pages":125,"category":83,"source":84,"url":126,"searchable":61},"01M4M3DJ5VFEQXAB390VB3QPK5","Verslag: 19-11-2025",6,"2025-11-19",21,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DJ5VFEQXAB390VB3QPK5.pdf",{"kind":80,"id":128,"title":129,"report_number":123,"report_date":124,"date":124,"pages":56,"category":83,"source":84,"url":130,"searchable":61},"01M4M3DM3VZ8SWXGN2D3G3S20C","Financieel verslag 19-11-2025","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DM3VZ8SWXGN2D3G3S20C.pdf",{"kind":80,"id":132,"title":133,"report_number":134,"report_date":135,"date":135,"pages":56,"category":83,"source":84,"url":136,"searchable":61},"01M4M3DEN96S8MPVPQTW6J0HMC","Financieel verslag 19-08-2025",5,"2025-08-19","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DEN96S8MPVPQTW6J0HMC.pdf",{"kind":80,"id":138,"title":139,"report_number":134,"report_date":135,"date":135,"pages":57,"category":83,"source":84,"url":140,"searchable":61},"01M4M3DGH73ZQS6XWKEE5XYEA8","Verslag: 19-08-2025","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DGH73ZQS6XWKEE5XYEA8.pdf",{"kind":80,"id":142,"title":143,"report_number":144,"report_date":145,"date":145,"pages":146,"category":83,"source":84,"url":147,"searchable":61},"01M4M3DD8809A6JT2VW5HMA238","Verslag: 19-05-2025",4,"2025-05-19",18,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DD8809A6JT2VW5HMA238.pdf",{"kind":80,"id":149,"title":150,"report_number":144,"report_date":145,"date":145,"pages":56,"category":83,"source":84,"url":151,"searchable":61},"01M4M3DBNYJ3F702TB3H28VHRA","Financieel verslag 19-05-2025","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DBNYJ3F702TB3H28VHRA.pdf",{"kind":80,"id":153,"title":154,"report_number":155,"report_date":156,"date":156,"pages":56,"category":83,"source":84,"url":157,"searchable":61},"01M4M3D8XNXQNC4ZRKTYFPFFVC","Financieel verslag 19-02-2025",3,"2025-02-19","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3D8XNXQNC4ZRKTYFPFFVC.pdf",{"kind":80,"id":159,"title":160,"report_number":155,"report_date":156,"date":156,"pages":161,"category":83,"source":84,"url":162,"searchable":61},"01M4M3DAF7CH4XG1AHZXP85W03","Verslag: 19-02-2025",17,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3DAF7CH4XG1AHZXP85W03.pdf",{"kind":80,"id":164,"title":165,"report_number":166,"report_date":167,"date":167,"pages":168,"category":83,"source":84,"url":169,"searchable":61},"01M4M3D65GCNH62H3FF74R10EA","Verslag: 19-11-2024",2,"2024-11-19",14,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3D65GCNH62H3FF74R10EA.pdf",{"kind":80,"id":171,"title":172,"report_number":166,"report_date":167,"date":167,"pages":56,"category":83,"source":84,"url":173,"searchable":61},"01M4M3D7MGVWZX9DJPSGGA83N2","Financieel verslag 19-11-2024","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3D7MGVWZX9DJPSGGA83N2.pdf",{"kind":80,"id":175,"title":176,"report_number":96,"report_date":177,"date":177,"pages":103,"category":83,"source":84,"url":178,"searchable":61},"01M4M3D4DJCCMQ858E1V0902DB","Verslag: 22-08-2024","2024-08-22","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3D4DJCCMQ858E1V0902DB.pdf",{"kind":80,"id":180,"title":181,"report_number":96,"report_date":177,"date":177,"pages":103,"category":83,"source":84,"url":182,"searchable":61},"01M4M3D31YCWWQFMCJDYB8EWDG","Financieel verslag 19-08-2024","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M4M3D31YCWWQFMCJDYB8EWDG.pdf",{"kind":92,"id":184,"title":185,"report_number":14,"date":186,"pages":96,"category":83,"source":34,"url":14,"searchable":45,"publication_type":187,"publication_number":188,"stored_at":74,"download_url":189},"01M4M3D0NYW8J7A5PACFNM7A4Y","Uitspraak faillissement na beëindiging surseance op 18 juli 2024","2024-07-19","declaration","13.ams.24.307.F.1306.1.24","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Fisa-therapeutics-bv-30284229\u002Fpublications\u002F01M4M3D0NYW8J7A5PACFNM7A4Y\u002Fdownload",[]]